Nike, Tesla, Humana, and More
These Stocks Are Moving the Most Today: Tesla, Levi Strauss, Humana, Constellation Brands, and More
Tesla extends losses following the release of third-quarter deliveries, and Levi Strauss tumbles after cutting its fiscal-year revenue outlook.
Stocks to Watch Wednesday: Tesla, Humana, Nike, Joby Aviation
Shares of the health insurer [tumbled 12% in afternoon trading](
Top Stock Movers Now: Nike, Tesla, Humana, and More
Key Takeaways Major U.S. indexes were little changed at midday Wednesday, as investors watch developments in the Middle East and the U.S. port strike. Nike shares fell Wednesday, a day after the company declined to offer a full-year outlook alongside its fiscal first-quarter results.
These Stocks Are Moving the Most Today: Humana, Nike, Tesla, Conagra, Joby Aviation, Caesars, and More
Humana stock sinks on Medicare Advantage troubles, Nike withdraws fiscal 2025 guidance as it changes chief executives, and Tesla reports third-quarter deliveries that came in slightly higher than estimates.
Stocks to Watch Wednesday: Nike, Occidental, Lufthansa, Tesla
Nike shares slid 5% in premarket trading. The sneaker company notched a 10% decline in quarterly revenue and a near-30% fall in profits from a
Midday stock movers: Nike, Tesla, Humana
Related: Analyst resets Tesla stock price target ahead of Q3 deliveries. Tesla is scheduled to post its Q3 financial results after the market close Oct. 23. Tesla stock is down 0.
Medicare Advantage giant Humana reels after ratings cut
The insurer’s stock sank to its lowest level in more than a decade after the federal government lowered the rating for one of ...
Humana Shares Plunge After Changes in Medicare Star Ratings
The stock slid more than 15% as the health insurer warned that a steep drop in the federal government’s quality ratings of ...
Humana’s Ratings Debacle Exacerbates Tough Year for New CEO
Humana Inc. shares plummeted the most in 15 years after the insurer suffered a drop in Medicare Advantage quality ratings, ...
Humana’s Star Rating Decline Prompts Hold Rating Amid Financial Uncertainty
Analyst Erin Wright of Morgan Stanley maintained a Hold rating on Humana (HUM – Research Report), with a price target of $374.00. Erin ...
Heard on the Street Wednesday Recap: The Humana Condition
Between the escalating conflict in the Middle East and the lead up to the U.S. presidential election, investors have had a ...
Humana cut to underperform by BofA on margin recovery delay
Humana (HUM) was downgraded to underperform by BofA, which cited an ongoing delay in margin recovery amid news the company ...
Buy Rating Affirmed: Humana’s Proactive Strategies to Mitigate Earnings Headwinds
Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Baxter from ...
For 2025, Insurers Pull Back Slightly On Medicare Advantage Footprints
Health insurance companies including CVS Health's Aetna, Cigna and Humana are pulling back slightly on their Medicare Advantage footprints after years of expansions.